AIDS in Brazil Case Solution & Answer

Abbott Labs has reached an impasse with the government of Brazil in the negotiations over the price of a new AIDS drug, Kaletra. The Brazilian government’s threat of compulsory licensing unless Abbott drastically reduced the price of Kaletra.
by
Rohit Deshpande,
Ricardo Reisen de Pinho
Source: Harvard Business School
4 pages.
Date Posted: February 23, 2006. Prod #: 506062-PDF-ENG
AIDS in Brazil Case Solution

Related Case Solutions:

Abbott and the AIDS Crisis (C): What Lies Ahead Brazil: Leading the BRICs? Abbott and the AIDS Crisis (C): What Lies Ahead? GlaxoSmithKline in Brazil: Public-Private Vaccine Partnerships Brazil vs. the U.S. at the WTO: The U.S.-Brazil Cotton Subsidy Dispute Brazil vs. the U.S. at the WTO: The U.S.-Brazil Cotton Subsidy Dispute Banco do Brazil, from Brazil to the world Abbott and the AIDS Crisis (A) Abbott and the AIDS Crisis (B) HIV, AIDS and Antigua and Barbuda